Treatment for inclusion body myositis
References
Additional references
Jump to:
Amato AA, Shebert RT. Inclusion body myositis in twins. Neurology 1998;51(2):598‐600.
Badrising UA, Maat‐Schieman M, van Duinen SG, Breedveld F, van Doorn P, van Engelen B, et al. Epidemiology of inclusion body myositis in the Netherlands: a nationwide study. Neurology 2000;55(9):1385‐8.
Benveniste O, Hilton‐Jones D. International Workshop on Inclusion Body Myositis held at the Institute of Myology, Paris, on 29 May 2009. Neuromuscular Disorders 2010;20(6):414‐21.
Cortese A, Machado P, Morrow J, Dewar L, Hiscock A, Miller A, et al. Longitudinal observational study of sporadic inclusion body myositis: implications for clinical trials. Neuromuscular Disorders 2013;23(5):404‐12.
Cox FM, Titulaer MJ, Sont JK, Wintzen AR, Verschuuren JJ, Badrising UA. A 12‐year follow‐up in sporadic inclusion body myositis: an end stage with major disabilities. Brain 2011;134(Pt 11):3167‐75.
Dalakas M C, Illa I. Common variable immunodeficiency and inclusion body myositis ‐ a distinct myopathy mediated by natural killer cells. Annals of Neurology 1995;37(6):806‐10.
Danon MJ, Perurena OH, Ronan S, Manaligod JR. Inclusion body myositis associated with systemic sarcoidosis. Canadian Journal of Neurological Sciences 1986;13(4):334‐6.
McMaster University. GRADEpro. Hamilton, Ontario: McMaster University, 2014. www.gradepro.org.
Griggs RC, Askanas V, DiMauro S, Engel AG, Karpati G, Mendell JR, et al. Inclusion body myositis and myopathies. Annals of Neurology 1995;38(5):705‐13.
Gutmann L, Govindan S, Riggs JE, Schochet SS. Inclusion body myositis and Sjogren's syndrome. Archives of Neurology 1985;42(10):1021‐2.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.
Hill M, Hughes T, Milford C. Treatment for swallowing difficulties (dysphagia) in chronic muscle disease. Cochrane Database of Systematic Reviews 2004, Issue 2. [DOI: 10.1002/14651858.CD004303.pub2]
Hilton‐Jones D, Miller A, Parton M, Holton J, Sewry C, Hanna MG. Inclusion body myositis: MRC Centre for Neuromuscular Diseases, IBM workshop, London, 13 June 2008. Neuromuscular Disorders 2010;20(2):142‐7.
Huizing M, Krasnewich DM. Hereditary inclusion body myopathy: a decade of progress. Biochimica et Biophysica Acta 2009;1792(9):881‐7.
Jackson CE, Barohn RJ, Gronseth G, Pandya S, Herbelin L. Inclusion body myositis functional rating scale: a reliable and valid measure of disease severity. Muscle & Nerve 2008;37(4):473–6.
Khraishi MM, Jay V, Keystone EC. Inclusion body myositis in association with vitamin B12 deficiency and Sjögren's syndrome. Journal of Rheumatology 1992;19(2):306‐9.
Lane RJ, Fulthorpe JJ, Hudgson P. Inclusion body myositis: a case with associated collagen vascular disease responding to treatment. Journal of Neurology, Neurosurgery & Psychiatry 1985;48(3):270‐3.
Lindberg C, Persson L, Oldfors A, Soderstrom T, Hedstrom A, Bjorkander J. Inclusion body myositis: association with immunodeficiency. Journal of the Neurological Sciences 1990;98 (Suppl):178.
Lotz BP, Engel AG, Nishino H, Stevens JC, Litchy WJ. Inclusion body myositis. Observations in 40 patients. Brain 1989;112(Pt 3):727‐47.
Needham M, Corbett A, Day T, Christiansen F, Fabian V, Mastaglia F. Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis. Journal of Clinical Neuroscience 2008;15(12):1350‐3.
Oldfors A, Moslemi AR, Fyhr IM, Holme E, Larsson NG, Lindberg C. Mitochondrial DNA deletions in muscle fibers in inclusion body myositis. Journal of Neuropathology & Experimental Neurology 1995;54(4):581‐7.
Phillips BA, Zilko PJ, Mastaglia FL. Prevalence of sporadic inclusion body myositis in Western Australia. Muscle & Nerve 2000;23(6):970‐2.
The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
Riggs JE, Schochet SS, Gutmann L, McComas CF, Rogers JS. Inclusion body myositis and chronic immune thrombocytopenia. Archives of Neurology 1984;41(1):93‐5.
Rose MR, McDermott MP, Thornton CA, Palenski C, Martens WB, Griggs RC. A prospective longitudinal natural history study of inclusion body myositis; implications for clinical trials. Neurology 2001;57(3):548‐50.
Soden M, Boundy K, Burrow D, Blumbergs P, Ahern M. Inclusion body myositis in association with rheumatoid arthritis. Journal of Rheumatology 1994;21:344‐6.
Tateyama M, Saito N, Fujihara K, Shiga Y, Takeda A, Narikawa K, et al. Familial inclusion body myositis: a report on two Japanese sisters. Internal Medicine (Tokyo, Japan) 2003;42(10):1035‐8.
Voet NBM, van der Kooi EL, Riphagen II, Lindeman E, van Engelen BGM, Geurts ACH. Strength training and aerobic exercise training for muscle disease. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: 10.1002/14651858.CD003907.pub4]
References to other published versions of this review
Jump to:
Rose MR, Griggs R, Dalakas M. Immunotherapy for inclusion body myositis. Cochrane Database of Systematic Reviews 1999, Issue 2. [DOI: 10.1002/14651858.CD001555]
Rose MR, Dalakas M, Griggs R, Leong K, Miller J, Walter MC. Treatment for inclusion body myositis. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD001555.pub2]
